Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-08

Clinical Trial Update: Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on pharyngeal electrical stimulation for amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pharyngeal electrical stimulation

Snippet

Sponsor: University of Ulm | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED